Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Vitamins01:30

Vitamins

Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced in our...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Executive summary of the consensus document on management of the transition of patients with inborn errors of intermediary metabolism.

Revista clinica espanola·2026
Same author

Multicenter study on long-term growth in patients with phenylketonuria.

Orphanet journal of rare diseases·2025
Same author

European guidelines on diagnosis and treatment of phenylketonuria: First revision.

Molecular genetics and metabolism·2025
Same author

Left ventricular dysfunction and intra-ventricular dyssynchrony in idiopathic pulmonary arterial hypertension.

International journal of cardiology·2022
Same author

Dragon 1 Protocol Manuscript: Training, Accreditation, Implementation and Safety Evaluation of Portal and Hepatic Vein Embolization (PVE/HVE) to Accelerate Future Liver Remnant (FLR) Hypertrophy.

Cardiovascular and interventional radiology·2022
Same author

Development of innovative simulation teaching for advanced general practice clinical pharmacists.

International journal of clinical pharmacy·2021

Related Experiment Video

Updated: May 8, 2026

One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure
09:28

One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure

Published on: June 25, 2010

Main issues in micronutrient supplementation in phenylketonuria.

A M Lammardo1, M Robert, J C Rocha

  • 1Department of Pediatrics, San Paolo Hospital, University of Milan, Milan, Italy.

Molecular Genetics and Metabolism
|September 11, 2013
PubMed
Summary

Phenylketonuria (PKU) patients require specialized low-phenylalanine diets supplemented with vitamins and minerals. Current supplements often exceed regulatory limits, necessitating exceptions and careful monitoring for nutritional balance.

Keywords:
MicronutrientsMineralsPhenylalaninePhenylketonuriaVitamins

More Related Videos

Modifying Levels of Maternal Dietary Folic Acid or Choline to Study the Impact of Deficiencies on Offspring Health Outcomes
03:19

Modifying Levels of Maternal Dietary Folic Acid or Choline to Study the Impact of Deficiencies on Offspring Health Outcomes

Published on: June 28, 2024

Related Experiment Videos

Last Updated: May 8, 2026

One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure
09:28

One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure

Published on: June 25, 2010

Modifying Levels of Maternal Dietary Folic Acid or Choline to Study the Impact of Deficiencies on Offspring Health Outcomes
03:19

Modifying Levels of Maternal Dietary Folic Acid or Choline to Study the Impact of Deficiencies on Offspring Health Outcomes

Published on: June 28, 2024

Area of Science:

  • Nutritional Science
  • Metabolic Disorders
  • Biochemistry

Background:

  • Phenylketonuria (PKU) management primarily relies on low-phenylalanine diets.
  • Vitamin and mineral (VM) supplements are crucial, often integrated into phenylalanine-free (phe-free) L-amino acid formulas.
  • Existing supplements frequently require regulatory exceptions due to micronutrient content exceeding EU guidelines per 100 kcal.

Purpose of the Study:

  • To analyze the regulatory landscape and nutritional composition of VM phe-free L-amino acid supplements for PKU.
  • To highlight the challenges in meeting micronutrient requirements within existing regulatory frameworks.
  • To emphasize the need for systematic monitoring and updated European guidelines for PKU nutritional management.

Main Methods:

  • Review of the EU Foods for Special Medical Purposes (FSMP) directive (1999/21/EC, amended by 2006/141/EC).
  • Analysis of typical micronutrient profiles in commercially available phe-free L-amino acid supplements.
  • Assessment of compliance with FSMP micronutrient limits per 100 kcal.

Main Results:

  • Most VM phe-free L-amino acid supplements exceed FSMP maximum micronutrient limits per 100 kcal due to low energy density.
  • Compositional exceptions to the FSMP directive are commonly granted for these supplements.
  • Annual nutritional follow-up is recommended for all PKU patients to prevent vitamin and mineral imbalances.

Conclusions:

  • Current VM phe-free L-amino acid supplements present regulatory challenges regarding micronutrient content.
  • Systematic monitoring of micronutrient intake is vital, especially when non-dietary PKU treatments are employed.
  • Development of European guidelines for essential micronutrient monitoring in PKU is needed.